These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 25440413)

  • 1. Non renal effects of aldosterone.
    Gomez-Sanchez CE
    Steroids; 2014 Dec; 91():1-2. PubMed ID: 25440413
    [No Abstract]   [Full Text] [Related]  

  • 2. Aldosterone as a renal growth factor.
    Thomas W; Dooley R; Harvey BJ
    Steroids; 2010; 75(8-9):550-4. PubMed ID: 19782095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid non-genomic vasoconstrictor actions of aldosterone in the renal microcirculation.
    Arima S
    J Steroid Biochem Mol Biol; 2006 Dec; 102(1-5):170-4. PubMed ID: 17045798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential ubiquitylation of the mineralocorticoid receptor is regulated by phosphorylation.
    Faresse N; Vitagliano JJ; Staub O
    FASEB J; 2012 Oct; 26(10):4373-82. PubMed ID: 22798426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms underlying rapid aldosterone effects in the kidney.
    Thomas W; Harvey BJ
    Annu Rev Physiol; 2011; 73():335-57. PubMed ID: 20809792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of aldosterone in renal physiology.
    Knochel JP; White MG
    Arch Intern Med; 1973 Jun; 131(6):876-84. PubMed ID: 4574888
    [No Abstract]   [Full Text] [Related]  

  • 7. Cyclosporine a and FK506 inhibit transcriptional activity of the human mineralocorticoid receptor: a cell-based model to investigate partial aldosterone resistance in kidney transplantation.
    Deppe CE; Heering PJ; Viengchareun S; Grabensee B; Farman N; Lombès M
    Endocrinology; 2002 May; 143(5):1932-41. PubMed ID: 11956176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular actions of aldosterone.
    Briet M; Schiffrin EL
    J Vasc Res; 2013; 50(2):89-99. PubMed ID: 23172373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human mineralocorticoid receptor expression renders cells responsive for nongenotropic aldosterone actions.
    Grossmann C; Benesic A; Krug AW; Freudinger R; Mildenberger S; Gassner B; Gekle M
    Mol Endocrinol; 2005 Jul; 19(7):1697-710. PubMed ID: 15761031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of aldosterone on renal handling of sodium, potassium and hydrogen ions.
    Paillard M
    Adv Nephrol Necker Hosp; 1977; 7():83-104. PubMed ID: 96680
    [No Abstract]   [Full Text] [Related]  

  • 11. Aldosterone stimulates fibronectin synthesis in renal fibroblasts through mineralocorticoid receptor-dependent and independent mechanisms.
    Chen D; Chen Z; Park C; Centrella M; McCarthy T; Chen L; Al-Omari A; Moeckel GW
    Gene; 2013 Nov; 531(1):23-30. PubMed ID: 23994292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The serum- and glucocorticoid-induced kinase is a physiological mediator of aldosterone action.
    Bhargava A; Fullerton MJ; Myles K; Purdy TM; Funder JW; Pearce D; Cole TJ
    Endocrinology; 2001 Apr; 142(4):1587-94. PubMed ID: 11250940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rho kinase pathway is likely responsible for the profibrotic actions of aldosterone in renal epithelial cells via inducing epithelial-mesenchymal transition and extracellular matrix excretion.
    Wei J; Li Z; Ma C; Zhan F; Wu W; Han H; Huang Y; Li W; Chen D; Peng Y
    Cell Biol Int; 2013 Jul; 37(7):725-30. PubMed ID: 23456826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aldosterone signaling modifies capillary formation by human bone marrow endothelial cells.
    Chen W; Valamanesh F; Mirshahi T; Soria J; Tang R; Agarwal MK; Mirshahi M
    Vascul Pharmacol; 2004 Jan; 40(6):269-77. PubMed ID: 15063830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid aldosterone actions on epithelial sodium channel trafficking and cell proliferation.
    Quinn S; Harvey BJ; Thomas W
    Steroids; 2014 Mar; 81():43-8. PubMed ID: 24269741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of aldosterone on renin release in the isolated bloodless perfused canine kidney.
    Greco JM; Murphy GP
    Invest Urol; 1972 Jan; 9(4):294-9. PubMed ID: 5058768
    [No Abstract]   [Full Text] [Related]  

  • 17. Aldosterone-stimulated PKC signalling cascades: from receptor to effector.
    Thomas W; McEneaney V; Harvey BJ
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):1049-51. PubMed ID: 17956276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Aldosterone and kidney diseases: an emergent paradigm with important clinical implications].
    Bertocchio JP; Jaisser F
    Nephrol Ther; 2011 Jun; 7(3):139-47. PubMed ID: 21144811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonistic effects of bone morphogenetic protein-4 and -7 on renal mesangial cell proliferation induced by aldosterone through MAPK activation.
    Otani H; Otsuka F; Inagaki K; Takeda M; Miyoshi T; Suzuki J; Mukai T; Ogura T; Makino H
    Am J Physiol Renal Physiol; 2007 May; 292(5):F1513-25. PubMed ID: 17244894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteopontin deficiency protects against aldosterone-induced inflammation, oxidative stress, and interstitial fibrosis in the kidney.
    Irita J; Okura T; Jotoku M; Nagao T; Enomoto D; Kurata M; Desilva VR; Miyoshi K; Matsui Y; Uede T; Denhardt DT; Rittiling SR; Higaki J
    Am J Physiol Renal Physiol; 2011 Oct; 301(4):F833-44. PubMed ID: 21734100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.